KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -96.3% | 16,733 | -78.6% | 0.00% | -100.0% |
| Q1 2022 | $108,000 | -9.2% | 78,099 | -20.4% | 0.00% | -33.3% |
| Q4 2021 | $119,000 | -62.3% | 98,130 | -18.7% | 0.00% | -50.0% |
| Q3 2021 | $316,000 | +109.3% | 120,678 | +324.7% | 0.01% | +100.0% |
| Q2 2021 | $151,000 | -12.7% | 28,418 | +72.2% | 0.00% | -62.5% |
| Q2 2020 | $173,000 | – | 16,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,727,751 | $4,527,000 | 3.67% |
| RA Capital Management | 10,874,613 | $28,491,000 | 0.40% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $498,000 | 0.26% |
| Samsara BioCapital, LLC | 601,162 | $1,575,000 | 0.25% |
| Orbimed Advisors | 3,438,998 | $9,010,000 | 0.10% |
| Towercrest Capital Management | 122,500 | $321,000 | 0.06% |
| Knights of Columbus Asset Advisors LLC | 236,757 | $620,000 | 0.06% |
| Matisse Capital | 56,100 | $147,000 | 0.05% |
| Taylor Wealth Management Partners | 43,990 | $115,000 | 0.04% |
| SYMONS CAPITAL MANAGEMENT INC | 14,346 | $37,000 | 0.02% |